Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 4, Pages 1831
Publisher
MDPI AG
Online
2021-02-13
DOI
10.3390/ijms22041831
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Adaptor protein ShcD/SHC4 interacts with Tie2 receptor to synergistically promote glioma cell invasion
- (2021) Manali Tilak et al. MOLECULAR CANCER RESEARCH
- Major response to temozolomide as first-line treatment for newly-diagnosed DDR2-mutated glioblastoma: A case report
- (2020) K. El Husseini et al. REVUE NEUROLOGIQUE
- The Glioma Stem Cell Model in the Era of Single-Cell Genomics
- (2020) Mario L. Suvà et al. CANCER CELL
- Roadmap for the Emerging Field of Cancer Neuroscience
- (2020) Michelle Monje et al. CELL
- Phenotype stability under dynamic brain-tumor environment stimuli maps glioblastoma progression in patients
- (2020) Vinodh N. Rajapakse et al. Science Advances
- Cancer Stem Cells: The Architects of the Tumor Ecosystem
- (2019) Briana C. Prager et al. Cell Stem Cell
- Calcium Signaling in Brain Cancers: Roles and Therapeutic Targeting
- (2019) Ahmed Maklad et al. Cancers
- Modeling Patient-Derived Glioblastoma with Cerebral Organoids
- (2019) Amanda Linkous et al. Cell Reports
- The third-generation EGFR inhibitor AZD9291 overcomes primary resistance by continuously blocking ERK signaling in glioblastoma
- (2019) Xuejiao Liu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Stem cell-associated heterogeneity in Glioblastoma results from intrinsic tumor plasticity shaped by the microenvironment
- (2019) Anne Dirkse et al. Nature Communications
- An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
- (2019) Cyril Neftel et al. CELL
- Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells
- (2019) Raghupathy Vengoji et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- MET in glioma: signaling pathways and targeted therapies
- (2019) Fangling Cheng et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Cancer modeling meets human organoid technology
- (2019) David Tuveson et al. SCIENCE
- A Phase II, Multicenter, Single-Arm Study of Mipsagargin (G-202) as a Second-Line Therapy Following Sorafenib for Adult Patients with Progressive Advanced Hepatocellular Carcinoma
- (2019) Devalingam Mahalingam et al. Cancers
- Store-Operated Ca2+ Entry in Tumor Progression: From Molecular Mechanisms to Clinical Implications
- (2019) Yih-Fung Chen et al. Cancers
- Molecular and Clinical Insights into the Invasive Capacity of Glioblastoma Cells
- (2019) Carlos Velásquez et al. Journal of Oncology
- Electrical and synaptic integration of glioma into neural circuits
- (2019) Humsa S. Venkatesh et al. NATURE
- Glutamatergic synaptic input to glioma cells drives brain tumour progression
- (2019) Varun Venkataramani et al. NATURE
- Synaptic proximity enables NMDAR signalling to promote brain metastasis
- (2019) Qiqun Zeng et al. NATURE
- Identification of Key Pathways and Genes in the Orai2 Mediated Classical and Mesenchymal Subtype of Glioblastoma by Bioinformatic Analyses
- (2019) Feng Yuan et al. DISEASE MARKERS
- ACTR-33. INFIGRATINIB (BGJ398) IN PATIENTS WITH RECURRENT GLIOMAS WITH FIBROBLAST GROWTH FACTOR RECEPTOR (FGFR) ALTERATIONS: A MULTICENTER PHASE II STUDY
- (2019) Andrew Lassman et al. NEURO-ONCOLOGY
- ΔNp73/ETS2 complex drives glioblastoma pathogenesis— targeting downstream mediators by rebastinib prolongs survival in preclinical models of glioblastoma
- (2019) Maren Cam et al. NEURO-ONCOLOGY
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2012–2016
- (2019) Quinn T Ostrom et al. NEURO-ONCOLOGY
- Transcriptional Regulation of INSR, the Insulin Receptor Gene
- (2019) Sandhya Payankaulam et al. Genes
- The Molecular Basis of G Protein–Coupled Receptor Activation
- (2018) William I. Weis et al. Annual Review of Biochemistry
- The hypoxic peri-arteriolar glioma stem cell niche, an integrated concept of five types of niches in human glioblastoma
- (2018) Diana A. Aderetti et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Epidermal Growth Factor Receptor Extracellular Domain Mutations in Glioblastoma Present Opportunities for Clinical Imaging and Therapeutic Development
- (2018) Zev A. Binder et al. CANCER CELL
- Co-targeting ephrin receptor tyrosine kinases A2 and A3 in cancer stem cells reduces growth of recurrent glioblastoma.
- (2018) Maleeha A Qazi et al. CANCER RESEARCH
- Differential effects of transient and sustained activation of BDNF-TrkB signaling
- (2018) Wei Guo et al. Developmental Neurobiology
- Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study
- (2018) Theodore W Laetsch et al. LANCET ONCOLOGY
- Glioblastoma niches: from the concept to the phenotypical reality
- (2018) Davide Schiffer et al. NEUROLOGICAL SCIENCES
- Efficacy of Larotrectinib in TRK Fusion–Positive Cancers in Adults and Children
- (2018) Alexander Drilon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gene Fusion in Malignant Glioma: An Emerging Target for Next-Generation Personalized Treatment
- (2018) Tao Xu et al. Translational Oncology
- Prognostic significance of epidermal growth factor receptor expression in glioma patients
- (2018) Junhong Li et al. OncoTargets and Therapy
- Store operated calcium entry is altered by the inhibition of receptors tyrosine kinase
- (2018) Noémie Emeriau et al. Oncotarget
- Angiogenesis in human brain tumors: screening of drug response through a patient-specific cell platform for personalized therapy
- (2018) Laura Guarnaccia et al. Scientific Reports
- Glioblastoma Model Using Human Cerebral Organoids
- (2018) Junko Ogawa et al. Cell Reports
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Repotrectinib (TPX-0005) Is a Next-Generation ROS1/TRK/ALK Inhibitor That Potently Inhibits ROS1/TRK/ALK Solvent- Front Mutations
- (2018) Alexander Drilon et al. Cancer Discovery
- Coral: Clear and Customizable Visualization of Human Kinome Data
- (2018) Kathleen S. Metz et al. Cell Systems
- The complement system in glioblastoma multiforme
- (2018) T. A. M. Bouwens van der Vlis et al. Acta Neuropathologica Communications
- Activation of ERBB4 in Glioblastoma Can Contribute to Increased Tumorigenicity and Influence Therapeutic Response
- (2018) Jacqueline Donoghue et al. Cancers
- Targeting mTOR in Glioblastoma: Rationale and Preclinical/Clinical Evidence
- (2018) Carmen Mecca et al. DISEASE MARKERS
- NTRK fusion-positive cancers and TRK inhibitor therapy
- (2018) Emiliano Cocco et al. Nature Reviews Clinical Oncology
- Open Targets Platform: new developments and updates two years on
- (2018) Denise Carvalho-Silva et al. NUCLEIC ACIDS RESEARCH
- Role of Pyk2 in Human Cancers
- (2018) Ting Shen et al. MEDICAL SCIENCE MONITOR
- Insulin Receptor Isoforms in Physiology and Disease: An Updated View
- (2017) Antonino Belfiore et al. ENDOCRINE REVIEWS
- Prospect of rindopepimut in the treatment of glioblastoma
- (2017) Aladine A. Elsamadicy et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Signaling adaptor ShcD suppresses extracellular signal-regulated kinase (Erk) phosphorylation distal to the Ret and Trk neurotrophic receptors
- (2017) Melanie K. B. Wills et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Src homology 2 domains enhance tyrosine phosphorylationin vivoby protecting binding sites in their target proteins from dephosphorylation
- (2017) Joshua A. Jadwin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ggplot2 - Elegant Graphics for Data Analysis (2nd Edition)
- (2017) Virgilio Gómez-Rubio Journal of Statistical Software
- The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2 Hi Macrophages in Breast Cancer and Pancreatic Neuroendocrine Tumors
- (2017) Allison S. Harney et al. MOLECULAR CANCER THERAPEUTICS
- Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications
- (2017) Tathiane M Malta et al. NEURO-ONCOLOGY
- Insulin-Like Growth Factor (IGF) Pathway Targeting in Cancer: Role of the IGF Axis and Opportunities for Future Combination Studies
- (2017) Aaron Simpson et al. Targeted Oncology
- Comparison of the effectiveness of erlotinib, gefitinib, and afatinib for treatment of non-small cell lung cancer in patients with common and rare EGFR gene mutations
- (2017) Pawel Krawczyk et al. Oncology Letters
- Safety and Antitumor Activity of the Multitargeted Pan-TRK, ROS1, and ALK Inhibitor Entrectinib: Combined Results from Two Phase I Trials (ALKA-372-001 and STARTRK-1)
- (2017) Alexander Drilon et al. Cancer Discovery
- A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion–Positive Solid Tumors
- (2017) Alexander Drilon et al. Cancer Discovery
- Single-Cell RNA-Seq Analysis of Infiltrating Neoplastic Cells at the Migrating Front of Human Glioblastoma
- (2017) Spyros Darmanis et al. Cell Reports
- Contribution of the Microenvironmental Niche to Glioblastoma Heterogeneity
- (2017) Ivy A. W. Ho et al. Biomed Research International
- Glial and stem cell expression of murine Fibroblast Growth Factor Receptor 1 in the embryonic and perinatal nervous system
- (2017) Jantzen C. Collette et al. PeerJ
- The Role of Hypoxia in Glioblastoma Invasion
- (2017) Ana Monteiro et al. Cells
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Calcium signaling orchestrates glioblastoma development: Facts and conjunctures
- (2016) Catherine Leclerc et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Mipsagargin, a novel thapsigargin-based PSMA-activated prodrug: results of a first-in-man phase I clinical trial in patients with refractory, advanced or metastatic solid tumours
- (2016) D Mahalingam et al. BRITISH JOURNAL OF CANCER
- Normalization of Tumor Vessels by Tie2 Activation and Ang2 Inhibition Enhances Drug Delivery and Produces a Favorable Tumor Microenvironment
- (2016) Jin-Sung Park et al. CANCER CELL
- Preclinical and first-in-human phase I studies of KW-2450, an oral tyrosine kinase inhibitor with insulin-like growth factor receptor-1/insulin receptor selectivity
- (2016) Gary K. Schwartz et al. CANCER SCIENCE
- RET Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 Patients
- (2016) Shumei Kato et al. CLINICAL CANCER RESEARCH
- FGFR inhibitors: Effects on cancer cells, tumor microenvironment and whole-body homeostasis (Review)
- (2016) MASARU KATOH INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Stem cell markers in glioma progression and recurrence
- (2016) Kirsten Hattermann et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Randomized phase II study of axitinib versus physicians best alternative choice of therapy in patients with recurrent glioblastoma
- (2016) J. Duerinck et al. JOURNAL OF NEURO-ONCOLOGY
- Novel TIE-2 inhibitor BAY-826 displaysin vivoefficacy in experimental syngeneic murine glioma models
- (2016) Hannah Schneider et al. JOURNAL OF NEUROCHEMISTRY
- Trifluoperazine, a Well-Known Antipsychotic, Inhibits Glioblastoma Invasion by Binding to Calmodulin and Disinhibiting Calcium Release Channel IP 3 R
- (2016) Seokmin Kang et al. MOLECULAR CANCER THERAPEUTICS
- Entrectinib, a Pan-TRK, ROS1, and ALK Inhibitor with Activity in Multiple Molecularly Defined Cancer Indications
- (2016) E. Ardini et al. MOLECULAR CANCER THERAPEUTICS
- DNA repair mechanisms and their clinical impact in glioblastoma
- (2016) Hélène Erasimus et al. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH
- Tyrosine receptor kinase B is a drug target in astrocytomas
- (2016) Jing Ni et al. NEURO-ONCOLOGY
- Targeting tyrosine receptor kinase B in gliomas
- (2016) Kelly V. Pinheiro et al. NEURO-ONCOLOGY
- Novel MET/TIE2/VEGFR2 inhibitor altiratinib inhibits tumor growth and invasiveness in bevacizumab-resistant glioblastoma mouse models
- (2016) Yuji Piao et al. NEURO-ONCOLOGY
- Epithelial-mesenchymal transition in glioblastoma progression
- (2016) YASUO IWADATE Oncology Letters
- Simultaneous targeting of Eph receptors in glioblastoma
- (2016) Sara Ferluga et al. Oncotarget
- Soluble Tie2 overrides the heightened invasion induced by anti-angiogenesis therapies in gliomas
- (2016) Nahir Cortes-Santiago et al. Oncotarget
- TrkB-containing exosomes promote the transfer of glioblastoma aggressiveness to YKL-40-inactivated glioblastoma cells
- (2016) Sandra Pinet et al. Oncotarget
- Imatinib and Nilotinib increase glioblastoma cell invasion via Abl-independent stimulation of p130Cas and FAK signalling
- (2016) Antonina Frolov et al. Scientific Reports
- IGF-IR: a new prognostic biomarker for human glioblastoma
- (2015) C Maris et al. BRITISH JOURNAL OF CANCER
- Neuronal Activity Promotes Glioma Growth through Neuroligin-3 Secretion
- (2015) Humsa S. Venkatesh et al. CELL
- Growth factors mediated cell signalling in prostate cancer progression: Implications in discovery of anti-prostate cancer agents
- (2015) Gaurav Joshi et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Targeting FGFR Signaling in Cancer
- (2015) M. Touat et al. CLINICAL CANCER RESEARCH
- Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
- (2015) O. van Tellingen et al. DRUG RESISTANCE UPDATES
- Cancer stem cells in glioblastoma
- (2015) Justin D. Lathia et al. GENES & DEVELOPMENT
- SOCE and cancer: Recent progress and new perspectives
- (2015) Jiansheng Xie et al. INTERNATIONAL JOURNAL OF CANCER
- High levels of c-Met is associated with poor prognosis in glioblastoma
- (2015) Stine Asferg Petterson et al. JOURNAL OF NEURO-ONCOLOGY
- FGF Signaling Is Necessary for Neurogenesis in Young Mice and Sufficient to Reverse Its Decline in Old Mice
- (2015) W. Kang et al. JOURNAL OF NEUROSCIENCE
- ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
- (2015) Congcong Zhang et al. JNCI-Journal of the National Cancer Institute
- Insulin-mediated signaling promotes proliferation and survival of glioblastoma through Akt activation
- (2015) Yuanying Gong et al. NEURO-ONCOLOGY
- Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions
- (2015) Sameer Agnihotri et al. NEURO-ONCOLOGY
- Store-Operated Calcium Channels
- (2015) Murali Prakriya et al. PHYSIOLOGICAL REVIEWS
- An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101
- (2015) R. C. Doebele et al. Cancer Discovery
- Hypoxia-Inducible Factor-1 in Physiological and Pathophysiological Angiogenesis: Applications and Therapies
- (2015) Agnieszka Zimna et al. Biomed Research International
- ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma
- (2015) Congcong Zhang et al. JNCI-Journal of the National Cancer Institute
- Anti-vascular endothelial growth factor therapy-induced glioma invasion is associated with accumulation of Tie2-expressing monocytes
- (2015) Konrad Gabrusiewicz et al. Oncotarget
- Epidermal Growth Factor Receptor in Glioma: Signal Transduction, Neuropathology, Imaging, and Radioresistance
- (2015) Kimmo J. Hatanpaa et al. NEOPLASIA
- ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an “integrated” diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma
- (2014) David E. Reuss et al. ACTA NEUROPATHOLOGICA
- Phase I study of sorafenib combined with radiation therapy and temozolomide as first-line treatment of high-grade glioma
- (2014) A F Hottinger et al. BRITISH JOURNAL OF CANCER
- Cell-Surface Receptors Transactivation Mediated by G Protein-Coupled Receptors
- (2014) Fabio Cattaneo et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Neurotrophin Signaling via TrkB and TrkC Receptors Promotes the Growth of Brain Tumor-initiating Cells
- (2014) Samuel Lawn et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Store-operated Ca2+ entry regulates glioma cell migration and invasion via modulation of Pyk2 phosphorylation
- (2014) Meng Zhu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- The ShcD signaling adaptor facilitates ligand-independent phosphorylation of the EGF receptor
- (2014) Melanie K. B. Wills et al. MOLECULAR BIOLOGY OF THE CELL
- Phase I/randomized phase II study of afatinib, an irreversible ErbB family blocker, with or without protracted temozolomide in adults with recurrent glioblastoma
- (2014) D. A. Reardon et al. NEURO-ONCOLOGY
- Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
- (2014) A. P. Patel et al. SCIENCE
- Sox2 Promotes Malignancy in Glioblastoma by Regulating Plasticity and Astrocytic Differentiation
- (2014) Artem D. Berezovsky et al. NEOPLASIA
- EGFR wild-type amplification and activation promote invasion and development of glioblastoma independent of angiogenesis
- (2013) Krishna M. Talasila et al. ACTA NEUROPATHOLOGICA
- EGFR and EGFRvIII in Glioblastoma: Partners in Crime
- (2013) Gelareh Zadeh et al. CANCER CELL
- EGFR Phosphorylates Tumor-Derived EGFRvIII Driving STAT3/5 and Progression in Glioblastoma
- (2013) Qi-Wen Fan et al. CANCER CELL
- EphA3 Maintains Tumorigenicity and Is a Therapeutic Target in Glioblastoma Multiforme
- (2013) Bryan W. Day et al. CANCER CELL
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- Something old, something new and something borrowed: emerging paradigm of insulin-like growth factor type 1 receptor (IGF-1R) signaling regulation
- (2013) Leonard Girnita et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- mTORC2 Regulates Mechanically Induced Cytoskeletal Reorganization and Lineage Selection in Marrow-Derived Mesenchymal Stem Cells
- (2013) Buer Sen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The Pathobiology of Collagens in Glioma
- (2013) Leo S. Payne et al. MOLECULAR CANCER RESEARCH
- IDH1/2 mutations target a key hallmark of cancer by deregulating cellular metabolism in glioma
- (2013) Chunzhi Zhang et al. NEURO-ONCOLOGY
- Comparative study of IDH1 mutations in gliomas by immunohistochemistry and DNA sequencing
- (2013) S. Agarwal et al. NEURO-ONCOLOGY
- STIM1 and Orai1 mediate CRAC channel activity and are essential for human glioblastoma invasion
- (2013) Rajender K. Motiani et al. PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
- Functional Cross Talk between CXCR4 and PDGFR on Glioblastoma Cells Is Essential for Migration
- (2013) Miriam Sciaccaluga et al. PLoS One
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- Abundance of Flt3 and its ligand in astrocytic tumors
- (2013) Kirches et al. OncoTargets and Therapy
- Mechanisms of Glioma-Associated Neovascularization
- (2012) Matthew E. Hardee et al. AMERICAN JOURNAL OF PATHOLOGY
- Teaching an old dogma new tricks: twenty years of Shc adaptor signalling
- (2012) Melanie K. B. Wills et al. BIOCHEMICAL JOURNAL
- Collagen recognition and transmembrane signalling by discoidin domain receptors
- (2012) Federico Carafoli et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Discoidin domain receptor tyrosine kinases: new players in cancer progression
- (2012) Rajeshwari R. Valiathan et al. CANCER AND METASTASIS REVIEWS
- The EphA2 Receptor Drives Self-Renewal and Tumorigenicity in Stem-like Tumor-Propagating Cells from Human Glioblastomas
- (2012) Elena Binda et al. CANCER CELL
- Angiopoietin-2 Functions as a Tie2 Agonist in Tumor Models, Where It Limits the Effects of VEGF Inhibition
- (2012) C. Daly et al. CANCER RESEARCH
- Ret Is a Multifunctional Coreceptor that Integrates Diffusible- and Contact-Axon Guidance Signals
- (2012) Dario Bonanomi et al. CELL
- The Definition of Primary and Secondary Glioblastoma
- (2012) H. Ohgaki et al. CLINICAL CANCER RESEARCH
- Perspective: Dynamics of receptor tyrosine kinase signaling complexes
- (2012) Bruce J. Mayer FEBS LETTERS
- Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity
- (2012) Y. Kim et al. GENES & DEVELOPMENT
- Met receptor tyrosine kinase signals through a cortactin–Gab1 scaffold complex, to mediate invadopodia
- (2012) Charles V. Rajadurai et al. JOURNAL OF CELL SCIENCE
- Angiotensin II Induces Epithelial-to-Mesenchymal Transition in Renal Epithelial Cells through Reactive Oxygen Species/Src/Caveolin-Mediated Activation of an Epidermal Growth Factor Receptor-Extracellular Signal-Regulated Kinase Signaling Pathway
- (2012) J. Chen et al. MOLECULAR AND CELLULAR BIOLOGY
- Pharmacologic Blockade of FAK Autophosphorylation Decreases Human Glioblastoma Tumor Growth and Synergizes with Temozolomide
- (2012) V. M. Golubovskaya et al. MOLECULAR CANCER THERAPEUTICS
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas
- (2012) Gang Wu et al. NATURE GENETICS
- On the origin of glioma
- (2012) Yiwen Jiang et al. UPSALA JOURNAL OF MEDICAL SCIENCES
- Differential Sensitivity of Glioma- versus Lung Cancer–Specific EGFR Mutations to EGFR Kinase Inhibitors
- (2012) Igor Vivanco et al. Cancer Discovery
- Genetics of adult glioma
- (2012) McKinsey L. Goodenberger et al. Cancer Genetics
- Elevated invasive potential of glioblastoma stem cells
- (2011) Lin Cheng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Fibroblast Growth Factor Receptor 1– 5-Hydroxytryptamine 1A Heteroreceptor Complexes and Their Enhancement of Hippocampal Plasticity
- (2011) Dasiel O. Borroto-Escuela et al. BIOLOGICAL PSYCHIATRY
- Angiogenesis and invasion in glioma
- (2011) Manabu Onishi et al. Brain Tumor Pathology
- Mosaic Amplification of Multiple Receptor Tyrosine Kinase Genes in Glioblastoma
- (2011) Matija Snuderl et al. CANCER CELL
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Cdc42-interacting protein 4 is a Src substrate that regulates invadopodia and invasiveness of breast tumors by promoting MT1-MMP endocytosis
- (2011) J. Hu et al. JOURNAL OF CELL SCIENCE
- Identification of a low–molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice
- (2011) Maxime Cazorla et al. JOURNAL OF CLINICAL INVESTIGATION
- Type 2 diabetes mellitus and obesity are independent risk factors for poor outcome in patients with high-grade glioma
- (2011) Lola B. Chambless et al. JOURNAL OF NEURO-ONCOLOGY
- Phospholipase C and Protein Kinase C-β 2 Mediate Insulin-Like Growth Factor II-Dependent Sphingosine Kinase 1 Activation
- (2011) Hesham M. El-Shewy et al. MOLECULAR ENDOCRINOLOGY
- Targeting the insulin-like growth factor-1 receptor by picropodophyllin as a treatment option for glioblastoma
- (2011) S. Yin et al. NEURO-ONCOLOGY
- c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype
- (2011) Y. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
- (2011) Michelle C. Mendoza et al. TRENDS IN BIOCHEMICAL SCIENCES
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of Glioma
- (2010) Houtan Noushmehr et al. CANCER CELL
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Caffeine-Mediated Inhibition of Calcium Release Channel Inositol 1,4,5-Trisphosphate Receptor Subtype 3 Blocks Glioblastoma Invasion and Extends Survival
- (2010) S. S. Kang et al. CANCER RESEARCH
- Angiopoietin-2 Regulates Gene Expression in TIE2-Expressing Monocytes and Augments Their Inherent Proangiogenic Functions
- (2010) S. B. Coffelt et al. CANCER RESEARCH
- Brain-derived neurotrophic factor and the development of structural neuronal connectivity
- (2010) Susana Cohen-Cory et al. Developmental Neurobiology
- PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas
- (2010) T. Ozawa et al. GENES & DEVELOPMENT
- Phase II study of sunitinib malate in patients with recurrent high-grade glioma
- (2010) B. Neyns et al. JOURNAL OF NEURO-ONCOLOGY
- Receptor Heterodimerization: A New Mechanism for Platelet-Derived Growth Factor Induced Resistance to Anti-Epidermal Growth Factor Receptor Therapy for Bladder Cancer
- (2010) Peter C. Black et al. JOURNAL OF UROLOGY
- ROS receptor tyrosine kinase: a new potential target for anticancer drugs
- (2010) Ibrahim Mustafa El-Deeb et al. MEDICINAL RESEARCH REVIEWS
- Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
- (2010) Lucia Ricci-Vitiani et al. NATURE
- Sorafenib exerts anti-glioma activity in vitro and in vivo
- (2010) Markus D. Siegelin et al. NEUROSCIENCE LETTERS
- CD133 suppresses neuroblastoma cell differentiation via signal pathway modification
- (2010) H Takenobu et al. ONCOGENE
- Crosstalk Between the PI3K/mTOR and MEK/ERK Pathways Involved in the Maintenance of Self-Renewal and Tumorigenicity of Glioblastoma Stem-Like Cells
- (2010) Jun Sunayama et al. STEM CELLS
- IDH1 Mutations Are Early Events in the Development of Astrocytomas and Oligodendrogliomas
- (2009) Takuya Watanabe et al. AMERICAN JOURNAL OF PATHOLOGY
- Epigenetic Regulation of c-ROS Receptor Tyrosine Kinase Expression in Malignant Gliomas
- (2009) H. J. Jun et al. CANCER RESEARCH
- Different Response of Human Glioma Tumor-initiating Cells to Epidermal Growth Factor Receptor Kinase Inhibitors
- (2009) Fabrizio Griffero et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- mTOR signaling at a glance
- (2009) M. Laplante et al. JOURNAL OF CELL SCIENCE
- Randomized Phase II Trial of Erlotinib Versus Temozolomide or Carmustine in Recurrent Glioblastoma: EORTC Brain Tumor Group Study 26034
- (2009) Martin J. van den Bent et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme
- (2009) David M. Peereboom et al. JOURNAL OF NEURO-ONCOLOGY
- Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- (2009) Roger Stupp et al. LANCET ONCOLOGY
- BMS-754807, a small molecule inhibitor of insulin-like growth factor-1R/IR
- (2009) J. M. Carboni et al. MOLECULAR CANCER THERAPEUTICS
- IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas
- (2009) Koichi Ichimura et al. NEURO-ONCOLOGY
- IDH1andIDH2Mutations in Gliomas
- (2009) Hai Yan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1
- (2009) S. Zhao et al. SCIENCE
- PI3K Signaling in Glioma-Animal Models and Therapeutic Challenges
- (2008) Christine K. Cheng et al. BRAIN PATHOLOGY
- Prognostic significance of c-Met expression in glioblastomas
- (2008) Doo-Sik Kong et al. CANCER
- Eph-Ephrin Bidirectional Signaling in Physiology and Disease
- (2008) Elena B. Pasquale CELL
- Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3
- (2008) D. D. Hu-Lowe et al. CLINICAL CANCER RESEARCH
- ErbB receptors and the development of the nervous system
- (2008) Carmen Birchmeier EXPERIMENTAL CELL RESEARCH
- EGFR family: Structure physiology signalling and therapeutic targets†
- (2008) Antony W. Burgess GROWTH FACTORS
- Phase II Study of Imatinib in Patients With Recurrent Gliomas of Various Histologies: A European Organisation for Research and Treatment of Cancer Brain Tumor Group Study
- (2008) Eric Raymond et al. JOURNAL OF CLINICAL ONCOLOGY
- Comprehensive genomic characterization defines human glioblastoma genes and core pathways
- (2008) Roger McLendon et al. NATURE
- Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts
- (2008) Gaspar J. Kitange et al. NEURO-ONCOLOGY
- An Integrated Genomic Analysis of Human Glioblastoma Multiforme
- (2008) D. W. Parsons et al. SCIENCE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started